Ad is loading...
RGAHX
Price
$80.70
Change
+$0.47 (+0.59%)
Updated
Nov 22 closing price
TSNRX
Price
$18.43
Change
+$0.07 (+0.38%)
Updated
Nov 22 closing price
Ad is loading...

RGAHX vs TSNRX

Header iconRGAHX vs TSNRX Comparison
Open Charts RGAHX vs TSNRXBanner chart's image
American Funds Growth Fund of Amer R5E
Price$80.70
Change+$0.47 (+0.59%)
VolumeN/A
CapitalizationN/A
Touchstone Sands Capital Select Gr R6
Price$18.43
Change+$0.07 (+0.38%)
VolumeN/A
CapitalizationN/A
RGAHX vs TSNRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGAHX vs. TSNRX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAHX is a StrongSell and TSNRX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 302B vs. TSNRX (2.58B). RGAHX pays higher dividends than TSNRX: RGAHX (0.64) vs TSNRX (0.00). RGAHX was incepted earlier than TSNRX: RGAHX (9 years) vs TSNRX (4 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. TSNRX (27.00). RGAHX has a lower initial minimum investment than TSNRX: RGAHX (250) vs TSNRX (50000). TSNRX annual gain was more profitable for investors over the last year : 38.78 vs. RGAHX (29.07).
RGAHXTSNRXRGAHX / TSNRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years4 years-
Gain YTD29.43127.279108%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets302B2.58B11,701%
Annual Yield % from dividends0.640.00-
Returns for 1 year29.0738.7875%
Returns for 3 years0.67-18.23-4%
Returns for 5 years56.56N/A-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRUS103.698.15
+8.53%
Kura Sushi USA
CZNC20.720.64
+3.19%
Citizens & Northern Corp
ABEV2.190.04
+1.86%
Ambev SA
FROG32.150.21
+0.66%
JFrog Ltd
CODX1.01-0.05
-4.72%
Co-Diagnostics